Portfolio Holdings Detail for ISIN IE0031442068
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDUS(USD) LSE
ETF TickerIDUS.LS(USD) CXE
ETF TickerIUSA.AS(EUR) CXE
ETF TickerIUSA.DE(EUR) CXE
ETF TickerIUSA.LS(GBX) CXE
ETF TickerIUSA.MI(EUR) CXE
ETF TickerIUSAz(USD) CXE
ETF TickerIUSA(EUR) ETF Plus
ETF TickerIDUS.L(GBP) LSE

Holdings detail for ABBV

Stock NameAbbVie Inc
TickerABBV(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS00287Y1091
LEIFR5LCKFTG8054YNNRU85

Show aggregate ABBV holdings

News associated with ABBV

Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
AbbVie (NYSE:ABBV) Reaches New 12-Month High After Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as […] - 2025-09-19 03:10:53
AbbVie (NYSE:ABBV) Upgraded by Berenberg Bank to Buy Rating
AbbVie (NYSE:ABBV – Get Free Report) was upgraded by investment analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Marketbeat reports. The firm currently has a $270.00 price target on the stock, up from their previous price target of $170.00. Berenberg […] - 2025-09-19 02:24:45
Noteworthy Thursday Option Activity: ZS, CRM, ABBV
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zscaler Inc (Symbol: ZS), where a total of 10,858 contracts have traded so far, representing approximately 1.1 million underlying shares. That amounts to about 58.1% of - 2025-09-18 16:21:04
Notable ETF Inflow Detected - ITOT, HD, ABBV, AMD
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P Total U.S. Stock Market ETF (Symbol: ITOT) where we have detected an approximate $179.9 million dollar inflow -- that's a 0.2% i - 2025-09-18 13:25:16
Guru Fundamental Report for ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks that also have st - 2025-09-18 10:39:12
AbbVie (NYSE:ABBV) Trading Up 1.8% on Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.8% on Wednesday after Berenberg Bank upgraded the stock from a hold rating to a buy rating. Berenberg Bank now has a $270.00 price target on the stock, up from their previous price target of $170.00. AbbVie traded as high as $221.55 and last traded at […] - 2025-09-18 03:08:42
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-17 10:34:46
AbbVie (NYSE:ABBV) Price Target Raised to $245.00
AbbVie (NYSE:ABBV – Get Free Report) had its target price boosted by equities researchers at Cantor Fitzgerald from $215.00 to $245.00 in a research note issued to investors on Monday, MarketBeat reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 13.28% from the […] - 2025-09-17 02:56:46
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-16 10:32:29
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-12 10:32:52
Company News for Sep 12, 2025
Companies in The News Are: TSLA, WBD, DOW, ABBV - 2025-09-12 10:18:00
The Best Stocks to Invest $50,000 In Right Now
Key PointsAbbVie is a Dividend King that's proven its resilience. - 2025-09-12 05:46:00
Notable Thursday Option Activity: ABBV, LRCX, UAL
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 26,476 contracts has been traded thus far today, a contract volume which is representative of approximately 2.6 - 2025-09-11 14:43:20
Noteworthy ETF Inflows: VONG, ABBV, HD, RCL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Russell 1000 Growth ETF (Symbol: VONG) where we have detected an approximate $454.7 million dollar inflow -- that's a 1.4% increase week ove - 2025-09-10 11:51:17
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-10 10:34:13
Daily Dividend Report: VZ,ESS,AVGO,SACH,ABBV,NUE
The Board of Directors at Verizon Communications today declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter. The quarterly dividend is payable on November 3, 2025 to Verizon shareholders of record at the c - 2025-09-05 12:59:15
Guru Fundamental Report for ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-09-04 10:32:24
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-29 10:33:22
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-27 10:34:48
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-26 10:34:00
Noteworthy ETF Inflows: SSO, ABBV, BAC, KO
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra S&P500 (Symbol: SSO) where we have detected an approximate $147.7 million dollar inflow -- that's a 2.1% increase week over week - 2025-08-25 13:36:49
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-22 10:34:21
ABBV Factor-Based Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-20 10:33:59
Noteworthy ETF Outflows: ACWI, ABBV, BAC, KO
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $160.0 million dollar outflow -- that's a 0.7% decrease week over week (f - 2025-08-15 11:48:20
Validea Detailed Fundamental Analysis - ABBV
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-15 10:31:59
3 Dividend Stocks to Double Up On Right Now
Key PointsAbbVie is a Dividend King with an especially attractive valuation. - 2025-08-15 05:53:00
ABBV Quantitative Stock Analysis
Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit ch - 2025-08-12 10:33:16
4 of My Favorite Dividend Stocks for the Next 5 Years
My favorite type of dividend stock to invest in is dividend growth stocks. I like companies that pay safe, reliable, and growing dividends. I care less about yield and more about dividend growth. - 2025-08-09 10:42:00

iShares Core S&P 500 UCITS ETF USD (Dist) ABBV holdings

DateNumber of ABBV Shares HeldBase Market Value of ABBV SharesLocal Market Value of ABBV SharesChange in ABBV Shares HeldChange in ABBV Base ValueCurrent Price per ABBV Share HeldPrevious Price per ABBV Share Held
2025-09-26 (Friday)626,057USD 138,114,435USD 138,114,435
2025-09-25 (Thursday)626,057ABBV holding increased by 237USD 136,818,497ABBV holding decreased by -855645USD 136,818,497237USD -855,645 USD 218.54 USD 219.99
2025-09-24 (Wednesday)625,820USD 137,674,142USD 137,674,142
2025-09-18 (Thursday)629,543ABBV holding increased by 238USD 139,752,251ABBV holding increased by 795414USD 139,752,251238USD 795,414 USD 221.99 USD 220.81
2025-09-17 (Wednesday)629,305ABBV holding increased by 238USD 138,956,837ABBV holding increased by 2914808USD 138,956,837238USD 2,914,808 USD 220.81 USD 216.26
2025-09-16 (Tuesday)629,067USD 136,042,029ABBV holding decreased by -849241USD 136,042,0290USD -849,241 USD 216.26 USD 217.61
2025-09-15 (Monday)629,067USD 136,891,270USD 136,891,270
2025-09-12 (Friday)629,067USD 137,350,489USD 137,350,489
2025-09-11 (Thursday)629,305USD 138,585,547USD 138,585,547
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ABBV by Blackrock for IE0031442068

Show aggregate share trades of ABBV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY237 218.540* 189.08
2025-09-18BUY238 221.990* 188.92
2025-09-17BUY238 220.810* 188.76
2025-08-19SELL-478 206.190* 188.33 Profit of 90,020 on sale
2025-08-15SELL-239 206.690* 188.14 Profit of 44,965 on sale
2025-08-13SELL-1,195 201.470* 188.07 Profit of 224,743 on sale
2025-08-12SELL-3,107 198.640* 188.01 Profit of 584,162 on sale
2025-08-07SELL-3,585 198.860* 187.96 Profit of 673,830 on sale
2025-08-05BUY239 198.550* 187.86
2025-07-31BUY720 189.020* 187.85
2025-07-28BUY240 188.520* 187.82
2025-07-25SELL-480 190.280* 187.81 Profit of 90,149 on sale
2025-07-24BUY240 190.830* 187.79
2025-07-18BUY240 189.260* 187.79
2025-07-14SELL-239 191.520* 187.74 Profit of 44,870 on sale
2025-07-08SELL-478 189.770* 187.67 Profit of 89,706 on sale
2025-07-02BUY1,440 190.750* 187.63
2025-06-24SELL-480 185.550* 187.71 Profit of 90,100 on sale
2025-06-23SELL-239 183.760* 187.73 Profit of 44,868 on sale
2025-06-20BUY1,339 185.300* 187.75
2025-06-12SELL-714 192.420* 187.76 Profit of 134,062 on sale
2025-06-11SELL-634 191.500* 187.74 Profit of 119,026 on sale
2025-06-06BUY240 189.830* 187.70
2025-06-02SELL-717 186.990* 187.72 Profit of 134,592 on sale
2025-05-29SELL-239 185.620* 187.74 Profit of 44,870 on sale
2025-05-27BUY239 185.720* 187.79
2025-05-23BUY239 183.260* 187.85
2025-05-21SELL-717 181.800* 187.93 Profit of 134,745 on sale
2025-05-16SELL-1,165 184.020* 188.00 Profit of 219,015 on sale
2025-05-15BUY956 181.680* 188.04
2025-05-14SELL-1,434 177.440* 188.12 Profit of 269,762 on sale
2025-05-13SELL-2,868 188.000* 188.12 Profit of 539,526 on sale
2025-05-07SELL-717 188.090* 188.15 Profit of 134,904 on sale
2025-05-02SELL-239 198.470* 188.02 Profit of 44,936 on sale
2025-04-29SELL-717 193.510* 187.87 Profit of 134,706 on sale
2025-04-24BUY239 180.370* 187.91
2025-04-22BUY956 173.780* 188.12
2025-04-16BUY239 171.680* 188.67
2025-04-15BUY239 176.800* 188.78
2025-04-11BUY478 175.050* 188.98
2025-04-09BUY1,195 179.840* 189.19
2025-04-08BUY3,585 175.670* 189.32
2025-04-07SELL-1,666 186.550* 189.34 Profit of 315,444 on sale
2025-04-04SELL-3,570 186.960* 189.36 Profit of 676,029 on sale
2025-04-02SELL-714 205.190* 189.22 Profit of 135,101 on sale
2025-04-01SELL-238 206.270* 189.06 Profit of 44,996 on sale
2025-03-31SELL-476 209.520* 188.86 Profit of 89,900 on sale
2025-03-28BUY476 205.290* 188.71
2025-03-25BUY714 201.340* 188.32
2025-03-24BUY952 209.170* 188.12
2025-03-21SELL-476 210.010* 187.90 Profit of 89,440 on sale
2025-03-20BUY476 211.960* 187.66
2025-03-19BUY952 212.250* 187.40
2025-03-17SELL-714 214.470* 186.85 Profit of 133,409 on sale
2025-03-14SELL-476 211.770* 186.58 Profit of 88,814 on sale
2025-03-13SELL-1,428 211.550* 186.32 Profit of 266,064 on sale
2025-03-12SELL-696 212.060* 186.04 Profit of 129,485 on sale
2025-03-11SELL-1,673 213.590* 185.74 Profit of 310,748 on sale
2025-03-10SELL-956 216.660* 185.40 Profit of 177,245 on sale
2025-03-06SELL-956 210.750* 184.79 Profit of 176,663 on sale
2025-03-05SELL-1,434 211.540* 184.49 Profit of 264,558 on sale
2025-03-04SELL-1,912 207.760* 184.22 Profit of 352,233 on sale
2025-02-28SELL-1,195 209.030* 183.61 Profit of 219,414 on sale
2025-02-26BUY478 203.010* 183.12
2025-02-24BUY478 204.080* 182.60
2025-02-21BUY239 202.080* 182.36
2025-02-20SELL-717 200.880* 182.12 Profit of 130,581 on sale
2025-02-14SELL-239 192.870* 181.44 Profit of 43,365 on sale
2025-02-13SELL-3,107 193.450* 181.28 Profit of 563,242 on sale
2025-02-12SELL-239 193.000* 181.12 Profit of 43,288 on sale
2025-02-06SELL-956 192.970* 180.52 Profit of 172,580 on sale
2025-02-05BUY239 191.750* 180.36
2025-02-04BUY1,673 189.950* 180.21
2025-01-29SELL-1,673 175.260* 180.15 Profit of 301,391 on sale
2025-01-28BUY478 174.810* 180.24
2025-01-24BUY239 170.300* 180.46
2025-01-22BUY478 169.200* 180.82
2025-01-16BUY478 173.700* 181.45
2025-01-15BUY239 171.350* 181.64
2025-01-10BUY478 175.170* 181.99
2025-01-02BUY717 179.440* 182.19
2024-12-31BUY478 177.700* 182.29
2024-12-27BUY239 178.010* 182.52
2024-12-20BUY717 175.580* 182.95
2024-12-19BUY239 171.520* 183.24
2024-12-18SELL-239 173.020* 183.51 Profit of 43,858 on sale
2024-12-17BUY478 175.380* 183.73
2024-12-13BUY239 173.370* 184.37
2024-12-11SELL-1,219 174.370* 184.66 Profit of 225,103 on sale
2024-12-10BUY239 175.670* 184.93
2024-12-06SELL-478 176.190* 185.49 Profit of 88,663 on sale
2024-12-05BUY239 176.170* 185.80
2024-12-04SELL-1,912 176.460* 186.12 Profit of 355,860 on sale
2024-12-03BUY717 181.500* 186.28
2024-12-02BUY1,195 181.770* 186.45
2024-11-27BUY239 183.080* 186.88
2024-11-26BUY1,673 181.140* 187.13
2024-11-21BUY717 171.730* 188.91
2024-11-20BUY478 167.760* 190.02
2024-11-19BUY239 166.570* 191.33
2024-11-18BUY478 166.280* 192.80
2024-11-12BUY956 171.090* 194.16
2024-11-11BUY478 174.430* 195.47
2024-11-08BUY1,912 199.500* 195.18
2024-11-07BUY1,673 200.510* 194.78
2024-11-06BUY1,912 201.200* 194.24
2024-11-05SELL-478 201.680* 193.56 Profit of 92,523 on sale
2024-11-04BUY478 200.470* 192.87
2024-11-01BUY1,673 203.550* 191.69
2024-10-28BUY1,195 189.680* 188.14
2024-10-25BUY2,629 187.850* 188.21
2024-10-23SELL-239 187.880* 187.65 Profit of 44,848 on sale
2024-10-21BUY239 186.540* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ABBV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19815,51815,4431,666,74348.9%
2025-09-18976,2242,4781,754,40055.6%
2025-09-17893,363202,143,24341.7%
2025-09-16560,8134451,384,14740.5%
2025-09-15832,08112,5222,007,97041.4%
2025-09-12690,8791,0411,419,50348.7%
2025-09-111,245,5213,6262,674,00146.6%
2025-09-10926,0481,6361,760,14352.6%
2025-09-09647,8323,9711,201,67553.9%
2025-09-08977,4966691,948,91150.2%
2025-09-05819,8212191,562,69552.5%
2025-09-04656,683161,245,75552.7%
2025-09-03679,3332101,725,01139.4%
2025-09-02571,4914261,368,66141.8%
2025-08-29518,4982,3001,787,56829.0%
2025-08-28512,2603621,422,95636.0%
2025-08-27499,4001,8991,449,92734.4%
2025-08-26475,100950932,72950.9%
2025-08-25403,4871,429974,13041.4%
2025-08-22670,58311,671,94640.1%
2025-08-21797,91023,6061,744,06245.8%
2025-08-20674,5081,9572,202,73830.6%
2025-08-19365,12317,9261,554,64923.5%
2025-08-18847,9668,4272,576,31532.9%
2025-08-15743,22511,1851,373,85554.1%
2025-08-141,018,8391,0761,755,74658.0%
2025-08-13528,6431,8831,268,54541.7%
2025-08-12462,4052,3491,254,91536.8%
2025-08-11692,0223,2991,700,04740.7%
2025-08-08556,3032001,659,04633.5%
2025-08-07931,2384,3311,865,75449.9%
2025-08-06736,3843041,460,02450.4%
2025-08-051,243,69722,3761,900,77565.4%
2025-08-04874,215421,689,34351.7%
2025-08-011,652,23020,2903,046,81854.2%
2025-07-311,890,89313,6273,855,82049.0%
2025-07-30784,201281,860,56442.1%
2025-07-29955,4701951,973,29748.4%
2025-07-28484,253341,192,80940.6%
2025-07-25540,3402761,401,47438.6%
2025-07-24473,197791,213,81939.0%
2025-07-23693,2401,2141,535,06145.2%
2025-07-22401,6161,0981,567,49325.6%
2025-07-21792,579221,928,37141.1%
2025-07-18567,4093071,490,68038.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.